Healthcare -
Biotechnology - NASDAQ - US
$ 5.235
-1.97 %
$ 1.59 B
Market Cap
52.35
P/E
Price Target
Average
129.23%
Revenue Forecast
Estimate
35.42%
EBIT
Estimate
--220.92%
Net Income
Estimate
138.66%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
MannKind Corporation
Wall Street analysts predict an average 1-year price target for MNKD of $12 , with forecasts ranging from
a
low of
$12 to a high of $12 .
MNKD Lowest Price Target
Wall Street Target
12 USD
129.23%
MNKD Average Price Target
Wall Street Target
12 USD
129.23%
MNKD Highest Price Target
Wall Street Target
12 USD
129.23%
REVENUE FORECAST
Revenue Forecast Chart MNKD
EBIT FORECAST
EBIT Forecast Chart MNKD
NET INCOME FORECAST
Net Income Chart MNKD